Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Chiesi, Eli Lilly, Johnson & Johnson, Protalix, Sanofi, Ultragenyx, Unicycive.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Almirall, Elevar, Summit, Tenpoint.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Koru Medical, Siemens Healthineers.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Biogen, Drug Farm, Glaukos, Guerbet, Immix , Johnson & Johnson, Shorla.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: CSD Labs, Nextbiomedical, Spectrum Dynamics.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Bioarctic, Eisai, Huahui, Imviva, Intellia, Innovent, Otsuka, Quoin.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Glaukos, Seno Medical.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Biogen, Cogent, Eisai, GSK, Mannkind, Merz.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abanza, Outset Medical, Spine Innovation.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akeso, Daiichi Sankyo, GKS, Ionis, Iregene, Mesoblast, Nanoscope, Sun Pharmaceutical.